These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 28737508)
1. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2. Wang J; Cheng P; Pavlyukov MS; Yu H; Zhang Z; Kim SH; Minata M; Mohyeldin A; Xie W; Chen D; Goidts V; Frett B; Hu W; Li H; Shin YJ; Lee Y; Nam DH; Kornblum HI; Wang M; Nakano I J Clin Invest; 2017 Aug; 127(8):3075-3089. PubMed ID: 28737508 [TBL] [Abstract][Full Text] [Related]
2. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma. Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387 [TBL] [Abstract][Full Text] [Related]
3. TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway. Cai L; Liu Y; Li Y; Liu B; Cao Y; Yang W; Wang B; Sun T J Neurooncol; 2024 Sep; 169(2):269-279. PubMed ID: 38884661 [TBL] [Abstract][Full Text] [Related]
4. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway. Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332 [TBL] [Abstract][Full Text] [Related]
5. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Kim SH; Joshi K; Ezhilarasan R; Myers TR; Siu J; Gu C; Nakano-Okuno M; Taylor D; Minata M; Sulman EP; Lee J; Bhat KP; Salcini AE; Nakano I Stem Cell Reports; 2015 Feb; 4(2):226-38. PubMed ID: 25601206 [TBL] [Abstract][Full Text] [Related]
6. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis. Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240 [TBL] [Abstract][Full Text] [Related]
7. EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma. Yu T; Zhou F; Tian W; Xu R; Wang B; Zeng A; Zhou Z; Li M; Wang Y; Zhang J Oncogene; 2023 Feb; 42(6):461-470. PubMed ID: 36517590 [TBL] [Abstract][Full Text] [Related]
8. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108 [TBL] [Abstract][Full Text] [Related]
9. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
10. NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway. Xiang J; Alafate W; Wu W; Wang Y; Li X; Xie W; Bai X; Li R; Wang M; Wang J Cell Death Dis; 2022 Jan; 13(1):58. PubMed ID: 35031599 [TBL] [Abstract][Full Text] [Related]
11. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis. Cheng T; Xu Y Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
13. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma. Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice. Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614 [TBL] [Abstract][Full Text] [Related]
15. Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis. Zheng X; Pang B; Gu G; Gao T; Zhang R; Pang Q; Liu Q Int J Biol Sci; 2017; 13(2):245-253. PubMed ID: 28255276 [TBL] [Abstract][Full Text] [Related]
16. PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration. Wang J; Shen S; You J; Wang Z; Li Y; Chen Y; Tuo Y; Chen D; Yu H; Zhang J; Wang F; Pang X; Xiao Z; Lan Q; Wang Y Cell Death Dis; 2024 Jul; 15(7):524. PubMed ID: 39043634 [TBL] [Abstract][Full Text] [Related]
17. NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells. Zhang Y; Yu H; He M; Liu W; Xiao S; Wang X; Huang P; Huang Q Neoplasma; 2024 Jun; 71(3):255-265. PubMed ID: 38764296 [TBL] [Abstract][Full Text] [Related]
18. Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma. Ahmad F; Patrick S; Sheikh T; Sharma V; Pathak P; Malgulwar PB; Kumar A; Joshi SD; Sarkar C; Sen E J Neurochem; 2017 Dec; 143(6):671-683. PubMed ID: 28833137 [TBL] [Abstract][Full Text] [Related]
19. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells. Grinshtein N; Rioseco CC; Marcellus R; Uehling D; Aman A; Lun X; Muto O; Podmore L; Lever J; Shen Y; Blough MD; Cairncross GJ; Robbins SM; Jones SJ; Marra MA; Al-Awar R; Senger DL; Kaplan DR Oncotarget; 2016 Sep; 7(37):59360-59376. PubMed ID: 27449082 [TBL] [Abstract][Full Text] [Related]
20. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. Li Q; Dong C; Cui J; Wang Y; Hong X J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]